- CA$29.32m
- CA$29.09m
- CA$1.91m
Annual cashflow statement for Cheelcare, fiscal year end - April 30th, CAD millions except per share, conversion factor applied.
2022 February 28th | 2023 February 28th | 2024 February 29th | 2025 February 28th | 2026 April 30th | |
|---|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
| Source: | PROSPECTUS | ARS | ARS | ARS | ARS |
| Standards: | IFRS | IFRS | IFRS | IFRS | IFRS |
| Status: | Final | Final | Final | Final | Final |
| Net Income/Starting Line | -0.008 | -0.12 | -0.044 | -0.066 | -4.86 |
| Depreciation | |||||
| Non-Cash Items | — | 0.034 | 0 | — | 2.75 |
| Unusual Items | |||||
| Other Non-Cash Items | |||||
| Changes in Working Capital | 0.008 | 0.008 | -0 | 0.021 | -1.68 |
| Change in Accounts Receivable | |||||
| Change in Inventories | |||||
| Change in Prepaid Expenses | |||||
| Change in Payable / Accrued Expenses | |||||
| Cash from Operating Activities | 0 | -0.079 | -0.044 | -0.044 | -3.53 |
| Capital Expenditures | — | — | — | — | -0.183 |
| Purchase of Fixed Assets | |||||
| Purchase / Acquisition of Intangibles | |||||
| Other Investing Cash Flow Items | — | — | — | -0.075 | -0.121 |
| Sale of Business | |||||
| Other Investing Cash Flow | |||||
| Cash from Investing Activities | — | — | — | -0.075 | -0.305 |
| Financing Cash Flow Items | — | 0.047 | 0 | — | 0.029 |
| Other Financing Cash Flow | |||||
| Net Issuance / Retirement of Stock | |||||
| Net Issuance / Retirement of Debt | |||||
| Cash from Financing Activities | 0 | 0.272 | 0 | — | 0.442 |
| Beginning Cash Balance | |||||
| Ending Cash Balance | |||||
| Net Change in Cash | 0 | 0.193 | -0.044 | -0.119 | -3.39 |